undamentalytics Newsletter
Sign in

Co-diagnostics, Inc. balance sheet

At the end of fiscal 2025, Co-diagnostics, Inc. had total assets of $24.7m, total liabilities of $4.1m and shareholders' equity of $20.6m. It held $11.9m in cash against $0 of debt: net cash of $11.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents411438923153124
Receivables—00122130000
Inventory0008252111
Total current assets41268115936232145
Goodwill————15—————
Total assets5227116012395642517
Accounts payable0001111321
Deferred revenue (current)0—000—0000
Total current liabilities12041346743
Short-term debt—2————————
Long-term debt02————————
Total debt0400000000
Total liabilities130526991044
Shareholders' equity4−126713411586542113
Net debt (negative = net cash)−33−1−43−89−23−15−3−12−4
Shares outstanding———————1m—5m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CODX vs ITOCCODX vs PLSECODX vs IMDXCODX vs QTEX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Co-diagnostics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Co-diagnostics, Inc.